Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

217 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Diabetes mortality: new light on an underestimated public health problem.
Fuller JH, Elford J, Goldblatt P, Adelstein AM. Fuller JH, et al. Diabetologia. 1983 May;24(5):336-41. doi: 10.1007/BF00251820. Diabetologia. 1983. PMID: 6873513
Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS).
Charlton-Menys V, Betteridge DJ, Colhoun H, Fuller J, France M, Hitman GA, Livingstone SJ, Neil HA, Newman CB, Szarek M, DeMicco DA, Durrington PN. Charlton-Menys V, et al. Among authors: fuller j. Diabetologia. 2009 Feb;52(2):218-25. doi: 10.1007/s00125-008-1176-8. Epub 2008 Oct 30. Diabetologia. 2009. PMID: 18972097 Clinical Trial.
Factors associated with progression to macroalbuminuria in microalbuminuric Type 1 diabetic patients: the EURODIAB Prospective Complications Study.
Giorgino F, Laviola L, Cavallo Perin P, Solnica B, Fuller J, Chaturvedi N. Giorgino F, et al. Among authors: fuller j. Diabetologia. 2004 Jun;47(6):1020-8. doi: 10.1007/s00125-004-1413-8. Epub 2004 May 29. Diabetologia. 2004. PMID: 15170497
Effect of atorvastatin on glycaemia progression in patients with diabetes: an analysis from the Collaborative Atorvastatin in Diabetes Trial (CARDS).
Livingstone SJ, Looker HC, Akbar T, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Fuller JH, Colhoun HM. Livingstone SJ, et al. Among authors: fuller jh. Diabetologia. 2016 Feb;59(2):299-306. doi: 10.1007/s00125-015-3802-6. Epub 2015 Nov 17. Diabetologia. 2016. PMID: 26577796 Free PMC article. Clinical Trial.
Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial.
Soedamah-Muthu SS, Livingstone SJ, Charlton-Menys V, Betteridge DJ, Hitman GA, Neil HA, Bao W, DeMicco DA, Preston GM, Fuller JH, Stehouwer CD, Schalkwijk CG, Durrington PN, Colhoun HM; CARDS Investigators. Soedamah-Muthu SS, et al. Among authors: fuller jh. Diabetologia. 2015 Jul;58(7):1494-502. doi: 10.1007/s00125-015-3586-8. Epub 2015 Apr 22. Diabetologia. 2015. PMID: 25899452 Free PMC article. Clinical Trial.
Predicting major outcomes in type 1 diabetes: a model development and validation study.
Soedamah-Muthu SS, Vergouwe Y, Costacou T, Miller RG, Zgibor J, Chaturvedi N, Snell-Bergeon JK, Maahs DM, Rewers M, Forsblom C, Harjutsalo V, Groop PH, Fuller JH, Moons KG, Orchard TJ. Soedamah-Muthu SS, et al. Among authors: fuller jh. Diabetologia. 2014 Nov;57(11):2304-14. doi: 10.1007/s00125-014-3358-x. Epub 2014 Sep 4. Diabetologia. 2014. PMID: 25186291 Free PMC article.
Higher dietary salt intake is associated with microalbuminuria, but not with retinopathy in individuals with type 1 diabetes: the EURODIAB Prospective Complications Study.
Engelen L, Soedamah-Muthu SS, Geleijnse JM, Toeller M, Chaturvedi N, Fuller JH, Schalkwijk CG, Stehouwer CD. Engelen L, et al. Among authors: fuller jh. Diabetologia. 2014 Nov;57(11):2315-23. doi: 10.1007/s00125-014-3367-9. Epub 2014 Aug 30. Diabetologia. 2014. PMID: 25172228 Free PMC article.
Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB Prospective Complications Study.
Schram MT, Chaturvedi N, Schalkwijk CG, Fuller JH, Stehouwer CD; EURODIAB Prospective Complications Study Group. Schram MT, et al. Among authors: fuller jh. Diabetologia. 2005 Feb;48(2):370-8. doi: 10.1007/s00125-004-1628-8. Epub 2005 Feb 4. Diabetologia. 2005. PMID: 15692810
Risk factors for progression to proliferative diabetic retinopathy in the EURODIAB Prospective Complications Study.
Porta M, Sjoelie AK, Chaturvedi N, Stevens L, Rottiers R, Veglio M, Fuller JH; EURODIAB Prospective Complications Study Group. Porta M, et al. Among authors: fuller jh. Diabetologia. 2001 Dec;44(12):2203-9. doi: 10.1007/s001250100030. Diabetologia. 2001. PMID: 11793022
Different risk factors of microangiopathy in patients with type I diabetes mellitus of short versus long duration. The EURODIAB IDDM Complications Study.
Karamanos B, Porta M, Songini M, Metelko Z, Kerenyi Z, Tamas G, Rottiers R, Stevens LK, Fuller JH. Karamanos B, et al. Among authors: fuller jh. Diabetologia. 2000 Mar;43(3):348-55. doi: 10.1007/s001250050053. Diabetologia. 2000. PMID: 10768096
217 results
Jump to page
Feedback